Salivary Gland Infection Market information, by diagnosis (plain radiography, sialography, and others), by treatment (medication, surgery, aspiration, and others), by end user- Forecast till 2032

Table of Content

1. Report Prologue

2. Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

2.3 Market Structure

2.4. Market Segmentation

3. Research Methodology

3.1 Research Process

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

3.5 Forecast Model

4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Mega Trends

4.5 Macroeconomic Indicators

5. Market Factor analysis

5.1 Value Chain Analysis

5.2 Porters Five Forces

5.3 Demand & Supply: Gap Analysis

5.4 Pricing Analysis

5.5 Investment Opportunity Analysis

5.6 Merger and Acquisition Landscape

5.7 Upcoming trends

5.7.1 Market trends

5.7.2 Technological trends

5.7.3 Insurance & Regulations

5.7.4 Others

6. Global salivary gland infection market by diagnosis

6.1 Plain radiography

6.2 Sialography

6.2.1 CT sialography (ultrafast technique)

6.2.2 Fluoroscopic/conventional sialography (with or without digital subtraction)

6.2.3 MR sialography

6.3 Computed tomography (CT)

6.4 Magnetic resonance imaging (MRI)

6.5 Radionuclide scintigraphy

6.6 High-resolution ultrasonography

6.7 Others

7. Global Salivary gland infection market by treatment

7.1 Medications

7.1.1 Antibiotics

7.1.1.1 Dicloxacillin

7.1.1.2 Cephalosporins

7.1.1.3 Clindamycin

7.1.14 Others

7.1.2 Others

7.2 Surgery

7.2.1 Removal of part of the parotid salivary gland

7.2.2. Removal of all of the parotid salivary gland

7.2.3 Removal of the submandibular salivary gland

7.2.4 Others

7.3 Aspiration

7.4 Home care

7.4.1 Water intake

7.4.2 Rest

7.4.3 Massaging the gland with heat

7.4.4 Stop smoking

7.4.5 Others

7.5 Others

8. Global Salivary Gland Infection market by end user

8.1 Hospitals & clinics

8.2 Medical research centers

8.3 Academic Institutes

8.4 Others

9. Global Salivary Gland Infection Market by region

9.1 Introduction

9.2 America

9.2.1 North America

9.2.1.1 The US

9.2.1.2 Canada

9.2.2 South America

9.3 Europe

9.3.1 Western Europe

9.3.1.1 Germany

9.3.1.2 France

9.3.1.3 Italy

9.3.1.4 Spain

9.3.1.5 UK

9.3.1.6 Rest of Western Europe

9.3.2 Eastern Europe

9.4 Asia

9.4.1 China

9.4.2 India

9.4.3 Japan

9.4.4 South Korea

9.4.5 Rest of Asia

9.5 Pacific

9.6 Middle East and Africa

9.6.1 UAE

9.6.2 Saudi Arabia

9.6.3 Egypt

9.6.4 Rest of Middle East and Africa

10. Competitive landscape

11. Company profile

12. Conclusion

12.1 Key findings

12.1.1 From CEO’s viewpoint

12.1.2 Unmet needs of the market

12.2 Key companies to watch

12.3 Prediction of salivary gland infection market

13. Appendix